Shannon McCarty alias Dr. Soul Scope-Creep

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Depression.

Depression

Supports

Several randomized crossover trials and early-phase studies show that inhaled nitrous oxide produces rapid antidepressant effects in adults with major depressive disorder and treatment‑resistant depression, with symptom improvements within hours to 24 hours after a single 25–50% inhalation session. ^[1][2] A recent systematic review and meta‑analysis of clinical trials on nitrous oxide for depression concludes that nitrous oxide demonstrates rapid, reproducible reductions in depressive symptoms in early‑phase trials, with statistically significant benefits at 2 and 24 hours and generally mild, transient adverse effects. Another systematic review and meta‑analysis focused on nitrous oxide in major depressive disorder and treatment‑resistant depression similarly reports a fast‑acting antidepressant effect, with significant symptom relief at 24 hours and sustained benefit at about one week in pooled data, while calling for more research on durability. ^[3][4] Meta‑analytic and systematic‑review evidence on sleep deprivation (usually total sleep deprivation or partial protocols combined with chronotherapy or light therapy) indicates that very short‑term sleep deprivation can produce a transient antidepressant effect in a substantial proportion of patients, particularly in bipolar depression, with improvements often seen in the first week of treatment. A broader meta‑analysis of sleep deprivation in depressive disorders finds that when applied over about 7–14 days in structured protocols, sleep deprivation can function as an effective, short‑term antidepressant intervention, although effects beyond this time frame are not reliably maintained.

Contradicts

The nitrous‑oxide evidence base is still limited to small, early‑phase trials, and the key systematic review emphasizes that while rapid effects are reproducible in the short term, it remains unclear whether benefits can be sustained over longer periods, especially beyond one week after a single 50% session or in routine practice. The nitrous‑oxide meta‑analysis notes that pooled effects at one week after a single 50% inhalation are not statistically significant, suggesting that any one‑off treatment has limited durability and that repeated dosing strategies are still experimental. ^[2] Current trials mostly involve highly selected adults with major depressive disorder or treatment‑resistant depression under close medical supervision, so generalizability to broader clinical populations, primary care settings, or self‑administration is uncertain. ^[1][3][4] For sleep deprivation, systematic reviews describe highly divergent short‑term efficacy across studies and highlight that response rates and effect sizes vary considerably between unipolar and bipolar depression, different deprivation protocols, and adjunctive treatments, indicating that the approach is not reliably effective for all depressed patients. The same meta‑analytic work shows that extending sleep‑deprivation protocols beyond about 14 days tends to worsen depressive symptoms rather than maintain benefit, and that even when short‑term improvement occurs, relapse after sleep recovery is common, limiting its utility as a stand‑alone, sustained treatment. Major clinical practice guidelines for depression do not recommend nitrous oxide or sleep deprivation as standard first‑line or maintenance treatments; they continue to prioritize antidepressant pharmacotherapy, structured psychotherapies, and, in selected cases, neuromodulation such as electroconvulsive therapy or repetitive transcranial magnetic stimulation, reflecting the experimental status of both nitrous oxide and sleep‑deprivation approaches.

Mainstream view

Mainstream medical practice views major depressive disorder and related depressive episodes as conditions best treated with evidence‑based modalities such as antidepressant medications, structured psychotherapies, lifestyle interventions, and, for severe or treatment‑resistant cases, neuromodulation and electroconvulsive therapy, all supported by large randomized trials and major guidelines. Nitrous oxide is currently regarded as a promising, rapid‑acting experimental intervention for adults with major depressive disorder and treatment‑resistant depression, with systematic reviews and meta‑analyses showing short‑term symptom reductions and acceptable acute safety, but it is not yet established as routine care because data on long‑term efficacy, optimal dosing schedules, comparative effectiveness, and real‑world safety are still limited. ^[1][3][4] Sleep‑deprivation‑based interventions are acknowledged in the literature as having potential short‑term antidepressant effects in some patients, especially within structured protocols over about one week, but the high variability in response, risk of symptom worsening or relapse, and practical difficulties mean they are considered niche, adjunctive, or research‑level strategies rather than mainstream first‑line treatments for depression. ^[2] [ref: Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Depression”

Rule: Minn. Stat. § 148.01, subd. 1(1), (2), (6); practice is not medicine

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Diagnosing and treating psychiatric disorders (Anxiety, Depression, PTSD) as chiropractic conditions..

Diagnosing and treating psychiatric disorders (Anxiety, Depression, PTSD) as chiropractic conditions.

Supports

Several randomized crossover trials and early-phase studies show that inhaled nitrous oxide produces rapid antidepressant effects in adults with major depressive disorder and treatment‑resistant depression, with symptom improvements within hours to 24 hours after a single 25–50% inhalation session. ^[1][2] A recent systematic review and meta‑analysis of clinical trials on nitrous oxide for depression concludes that nitrous oxide demonstrates rapid, reproducible reductions in depressive symptoms in early‑phase trials, with statistically significant benefits at 2 and 24 hours and generally mild, transient adverse effects. Another systematic review and meta‑analysis focused on nitrous oxide in major depressive disorder and treatment‑resistant depression similarly reports a fast‑acting antidepressant effect, with significant symptom relief at 24 hours and sustained benefit at about one week in pooled data, while calling for more research on durability. ^[3][4] Meta‑analytic and systematic‑review evidence on sleep deprivation (usually total sleep deprivation or partial protocols combined with chronotherapy or light therapy) indicates that very short‑term sleep deprivation can produce a transient antidepressant effect in a substantial proportion of patients, particularly in bipolar depression, with improvements often seen in the first week of treatment. A broader meta‑analysis of sleep deprivation in depressive disorders finds that when applied over about 7–14 days in structured protocols, sleep deprivation can function as an effective, short‑term antidepressant intervention, although effects beyond this time frame are not reliably maintained.

Contradicts

The nitrous‑oxide evidence base is still limited to small, early‑phase trials, and the key systematic review emphasizes that while rapid effects are reproducible in the short term, it remains unclear whether benefits can be sustained over longer periods, especially beyond one week after a single 50% session or in routine practice. The nitrous‑oxide meta‑analysis notes that pooled effects at one week after a single 50% inhalation are not statistically significant, suggesting that any one‑off treatment has limited durability and that repeated dosing strategies are still experimental. ^[2] Current trials mostly involve highly selected adults with major depressive disorder or treatment‑resistant depression under close medical supervision, so generalizability to broader clinical populations, primary care settings, or self‑administration is uncertain. ^[1][3][4] For sleep deprivation, systematic reviews describe highly divergent short‑term efficacy across studies and highlight that response rates and effect sizes vary considerably between unipolar and bipolar depression, different deprivation protocols, and adjunctive treatments, indicating that the approach is not reliably effective for all depressed patients. The same meta‑analytic work shows that extending sleep‑deprivation protocols beyond about 14 days tends to worsen depressive symptoms rather than maintain benefit, and that even when short‑term improvement occurs, relapse after sleep recovery is common, limiting its utility as a stand‑alone, sustained treatment. Major clinical practice guidelines for depression do not recommend nitrous oxide or sleep deprivation as standard first‑line or maintenance treatments; they continue to prioritize antidepressant pharmacotherapy, structured psychotherapies, and, in selected cases, neuromodulation such as electroconvulsive therapy or repetitive transcranial magnetic stimulation, reflecting the experimental status of both nitrous oxide and sleep‑deprivation approaches.

Mainstream view

Mainstream medical practice views major depressive disorder and related depressive episodes as conditions best treated with evidence‑based modalities such as antidepressant medications, structured psychotherapies, lifestyle interventions, and, for severe or treatment‑resistant cases, neuromodulation and electroconvulsive therapy, all supported by large randomized trials and major guidelines. Nitrous oxide is currently regarded as a promising, rapid‑acting experimental intervention for adults with major depressive disorder and treatment‑resistant depression, with systematic reviews and meta‑analyses showing short‑term symptom reductions and acceptable acute safety, but it is not yet established as routine care because data on long‑term efficacy, optimal dosing schedules, comparative effectiveness, and real‑world safety are still limited. ^[1][3][4] Sleep‑deprivation‑based interventions are acknowledged in the literature as having potential short‑term antidepressant effects in some patients, especially within structured protocols over about one week, but the high variability in response, risk of symptom worsening or relapse, and practical difficulties mean they are considered niche, adjunctive, or research‑level strategies rather than mainstream first‑line treatments for depression. ^[2] [ref: Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Anxiety”

Rule: Minn. Stat. § 148.01, subd. 1(2), (6)

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Treatment of Anxiety and Depression.

Treatment of Anxiety and Depression

Supports

Several randomized crossover trials and early-phase studies show that inhaled nitrous oxide produces rapid antidepressant effects in adults with major depressive disorder and treatment‑resistant depression, with symptom improvements within hours to 24 hours after a single 25–50% inhalation session. ^[1][2] A recent systematic review and meta‑analysis of clinical trials on nitrous oxide for depression concludes that nitrous oxide demonstrates rapid, reproducible reductions in depressive symptoms in early‑phase trials, with statistically significant benefits at 2 and 24 hours and generally mild, transient adverse effects. Another systematic review and meta‑analysis focused on nitrous oxide in major depressive disorder and treatment‑resistant depression similarly reports a fast‑acting antidepressant effect, with significant symptom relief at 24 hours and sustained benefit at about one week in pooled data, while calling for more research on durability. ^[3][4] Meta‑analytic and systematic‑review evidence on sleep deprivation (usually total sleep deprivation or partial protocols combined with chronotherapy or light therapy) indicates that very short‑term sleep deprivation can produce a transient antidepressant effect in a substantial proportion of patients, particularly in bipolar depression, with improvements often seen in the first week of treatment. A broader meta‑analysis of sleep deprivation in depressive disorders finds that when applied over about 7–14 days in structured protocols, sleep deprivation can function as an effective, short‑term antidepressant intervention, although effects beyond this time frame are not reliably maintained.

Contradicts

The nitrous‑oxide evidence base is still limited to small, early‑phase trials, and the key systematic review emphasizes that while rapid effects are reproducible in the short term, it remains unclear whether benefits can be sustained over longer periods, especially beyond one week after a single 50% session or in routine practice. The nitrous‑oxide meta‑analysis notes that pooled effects at one week after a single 50% inhalation are not statistically significant, suggesting that any one‑off treatment has limited durability and that repeated dosing strategies are still experimental. ^[2] Current trials mostly involve highly selected adults with major depressive disorder or treatment‑resistant depression under close medical supervision, so generalizability to broader clinical populations, primary care settings, or self‑administration is uncertain. ^[1][3][4] For sleep deprivation, systematic reviews describe highly divergent short‑term efficacy across studies and highlight that response rates and effect sizes vary considerably between unipolar and bipolar depression, different deprivation protocols, and adjunctive treatments, indicating that the approach is not reliably effective for all depressed patients. The same meta‑analytic work shows that extending sleep‑deprivation protocols beyond about 14 days tends to worsen depressive symptoms rather than maintain benefit, and that even when short‑term improvement occurs, relapse after sleep recovery is common, limiting its utility as a stand‑alone, sustained treatment. Major clinical practice guidelines for depression do not recommend nitrous oxide or sleep deprivation as standard first‑line or maintenance treatments; they continue to prioritize antidepressant pharmacotherapy, structured psychotherapies, and, in selected cases, neuromodulation such as electroconvulsive therapy or repetitive transcranial magnetic stimulation, reflecting the experimental status of both nitrous oxide and sleep‑deprivation approaches.

Mainstream view

Mainstream medical practice views major depressive disorder and related depressive episodes as conditions best treated with evidence‑based modalities such as antidepressant medications, structured psychotherapies, lifestyle interventions, and, for severe or treatment‑resistant cases, neuromodulation and electroconvulsive therapy, all supported by large randomized trials and major guidelines. Nitrous oxide is currently regarded as a promising, rapid‑acting experimental intervention for adults with major depressive disorder and treatment‑resistant depression, with systematic reviews and meta‑analyses showing short‑term symptom reductions and acceptable acute safety, but it is not yet established as routine care because data on long‑term efficacy, optimal dosing schedules, comparative effectiveness, and real‑world safety are still limited. ^[1][3][4] Sleep‑deprivation‑based interventions are acknowledged in the literature as having potential short‑term antidepressant effects in some patients, especially within structured protocols over about one week, but the high variability in response, risk of symptom worsening or relapse, and practical difficulties mean they are considered niche, adjunctive, or research‑level strategies rather than mainstream first‑line treatments for depression. ^[2] [ref: Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Anxiety”

Rule: Minn. Stat. § 148.01

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Anxiety.

Anxiety

Supports

The influencer’s claim is just the single word “Anxiety,” so the broad, evidence-based position is that anxiety disorders (such as generalized anxiety disorder, panic disorder, social anxiety disorder) are real, common, and have effective treatments with strong evidence support. ^{[5][6][7][10][11][12]} Clinical practice guidelines (e. g. , NICE, Canadian, WHO, WFSBP, Brazilian, AAFP) and multiple systematic reviews and meta-analyses consistently show that anxiety disorders are highly prevalent, cause significant functional impairment, and are amenable to evidence-based psychotherapy and pharmacotherapy. High‑quality evidence supports cognitive behavioral therapy (CBT) as a first‑line psychotherapeutic treatment for generalized anxiety disorder and other anxiety disorders, with multiple randomized controlled trials and meta‑analyses demonstrating moderate to strong efficacy compared with waitlist, usual care, or pill placebo. ^[8][9] CBT reduces worry, physical anxiety symptoms, and functional impairment, and benefits are often sustained over follow‑up. Systematic reviews and meta‑analyses also support selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs) as first‑line pharmacologic treatments for generalized anxiety disorder and other anxiety disorders, with clear superiority to placebo and generally favorable tolerability. Major guidelines recommend SSRIs/SNRIs or CBT as first‑line options, and often state that combining medication with psychotherapy can be more effective for some patients than either alone. Other agents such as pregabalin, certain atypical antipsychotics, and benzodiazepines have evidence of benefit in some anxiety disorders, but are typically second‑line because of side‑effect or dependence concerns. Overall, there is strong, high‑quality evidence that anxiety disorders are medical/psychiatric conditions with identifiable diagnostic criteria, neurobiological and psychological underpinnings, and multiple effective treatments.

Contradicts

None of the indexed clinical trials listed (which focus on chemotherapy plus immunotherapy for Epstein–Barr virus–associated gastric cancer, home caffeine for apnea of prematurity, axitinib with radiotherapy for hepatocellular carcinoma, or antimicrobial photodynamic therapy for dental biofilm) provide any evidence directly about anxiety or its treatment, and therefore they neither support nor refute any specific influencer claims about anxiety. ^{[5][6][7][8][9][11][12]} Without a more specific influencer statement (for example, that anxiety is “not a real medical condition,” “cannot be treated with medication,” “only breathwork works,” or “SSRIs never help”), it is not possible to identify a precise claim that is contradicted. However, broad content‑creator narratives that deny the medical reality of anxiety disorders or claim that evidence‑based treatments such as CBT or SSRIs/SNRIs are ineffective are clearly inconsistent with the large body of randomized controlled trials, meta‑analyses, and guidelines showing these treatments to be beneficial. ^[10] Likewise, strong claims that one single lifestyle intervention or supplement cures all anxiety, or that people should never use evidence‑based medications or psychotherapy, are not supported by the mainstream evidence base and would be contradicted by existing high‑quality data.

Mainstream view

The mainstream medical and scientific position is that anxiety disorders (including generalized anxiety disorder, panic disorder, social anxiety disorder, specific phobias, and related conditions) are common, clinically significant mental health disorders characterized by excessive fear, worry, and associated physical and cognitive symptoms that impair functioning. ^{[5][6][7][9][10][11][12]} They arise from an interaction of genetic vulnerability, neurobiological changes (e. g. , in neurotransmitter systems and fear circuits), psychological factors (such as cognitive biases and maladaptive coping), and environmental stressors. Anxiety disorders are diagnosed based on standardized criteria and can be reliably distinguished from normal, transient anxiety. High‑quality evidence supports a range of effective treatments. First‑line care typically includes cognitive behavioral therapy and/or pharmacotherapy with SSRIs or SNRIs. Other psychotherapies (such as other forms of structured cognitive or exposure‑based therapies) and certain medications may be used depending on the specific disorder, severity, comorbidities, and patient preference. Benzodiazepines can relieve acute anxiety but are usually reserved for short‑term use or second‑line roles due to risks of dependence, cognitive side effects, and interaction with other substances. Mind–body strategies (such as relaxation training, mindfulness‑based interventions, and biofeedback) and lifestyle changes (sleep hygiene, physical activity, reduced caffeine and substances, social support) can be helpful adjuncts but do not replace the need for evidence‑based core treatments in moderate‑to‑severe or persistent cases. Major guidelines emphasize stepped care, individualized treatment planning, monitoring for response and adverse effects, and attention to comorbid conditions and suicide risk. Anxiety disorders are therefore viewed as real, treat Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). ^[8]

In their own wordsView sourceArchived copy

“Anxiety”

Rule: Minn. Stat. § 148.01, subd. 1(1), (2)

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure PTSD.

PTSD

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“PTSD”

Rule: Minn. Stat. § 148.01, subd. 1(2), (6)

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Trauma.

Trauma

Supports

Mainstream diagnostic systems and guidelines define psychological trauma as exposure to events involving actual or threatened death, serious injury, or sexual violence, experienced directly, witnessed, or learned about when they occur to close others.^[17][23] Trauma is recognized as a key contributor to mental health outcomes across the lifespan, associated with posttraumatic stress disorder (PTSD), depression, anxiety, substance use disorders, and other psychiatric conditions.^{[11][13][14][23]} Major guidelines for PTSD (e.g., from the American Psychological Association and WHO) explicitly anchor PTSD diagnosis in prior trauma exposure and document that such exposure can lead to persistent intrusive memories, avoidance, negative mood and cognition, and hyperarousal that interfere with functioning.^[13][14][18] Large epidemiologic surveys show that exposure to traumatic events is common worldwide and is associated with increased risk of mental and physical health problems, reinforcing the central role of trauma in public mental health.^{[1][2][9][23]} Clinical and cohort studies of physical trauma (e.g., major injuries) demonstrate high rates of new-onset mental health conditions and long-term psychological symptoms after trauma, supporting the claim that trauma has enduring health impacts.^{[4][5][10][23]} Scoping and focused reviews of trauma-informed care frameworks in mental health and general healthcare settings further support the notion that acknowledging trauma and adapting services to minimize re-traumatization can improve patient experience and may benefit outcomes, although the evidence base is still developing.^[3][6][7][8]

Contradicts

Although trauma is clearly associated with adverse mental health outcomes, high-quality evidence emphasizes that not everyone exposed to traumatic events develops PTSD or other psychiatric disorders, and many individuals show resilience or only transient distress.^{[1][2][11][13][14][23]} Overly broad influencer claims that equate any distressing experience with "trauma" or suggest that trauma inevitably causes chronic mental illness are not supported by mainstream definitions, which require events that are life-threatening or severely threatening to physical integrity, and emphasize heterogeneity of responses.^{[17][19][23][25]} Some popular narratives portray trauma-informed care as a fully validated, universally effective model across all healthcare settings, but systematic and scoping reviews highlight that the empirical evidence for specific trauma-informed interventions and their impact on hard clinical outcomes remains limited and methodologically variable, indicating that this area is still evolving rather than definitively established.^{[3][6][8][10]} If the influencer claims that trauma underlies virtually all medical or psychiatric conditions or that trauma is solely responsible for complex illnesses, this goes beyond current evidence, which recognizes trauma as an important but not exclusive determinant among multiple biological, psychological, and social factors.^{[13][17][19][23]}

Mainstream view

The mainstream medical and scientific position is that trauma refers to exposure to events involving actual or threatened death, serious injury, or sexual violence (including direct experience, witnessing, or learning about such events affecting close others), and that these experiences can lead to significant and sometimes long-lasting psychological and physical health consequences for a subset of exposed individuals.^{[11][13][14][17][19][23][25]} Trauma is considered a major risk factor for PTSD and a contributor to depression, anxiety, substance use disorders, and other mental health conditions, but responses are highly variable, with many people experiencing transient symptoms or demonstrating resilience.^{[11][13][14][17][23]} Guidelines for PTSD and complex trauma emphasize careful assessment of trauma history, evidence-based psychotherapies (such as trauma-focused cognitive behavioral therapies and EMDR), and a growing interest in trauma-informed approaches that seek to recognize trauma, avoid re-traumatization, and provide safe, collaborative care.^{[13][14][18][22][23]} At the same time, mainstream experts caution against pathologizing all adversity as trauma or assuming a simple, deterministic relationship between trauma and later illness; instead, they view trauma within a broader biopsychosocial framework that includes genetics, environment, social determinants, and ongoing stressors.^{[13][17][19][23]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Trauma”

Rule: Minn. Stat. § 148.01

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Stress.

Stress

Supports

The very broad claim that stress affects health is strongly supported by high-quality evidence, especially for chronic and high perceived stress as a risk factor for multiple diseases and for the benefit of stress-management interventions. ^{[18][21][22][24]} Large epidemiologic cohorts show that people who report high stress or that stress strongly affects their health have higher risks of coronary heart disease, cardiovascular events, multimorbidity and mortality, even after adjustment for traditional risk factors. ^[23] Meta-analytic work has found high perceived stress associated with a moderately increased risk of incident coronary heart disease, with pooled risk ratios around 1. 2–1. 3. Systematic reviews and narrative reviews of chronic stress pathways describe well-characterized biological mechanisms: activation of the hypothalamic–pituitary–adrenal (HPA) axis and sympathetic nervous system, sustained elevations of cortisol and catecholamines, endothelial dysfunction, pro-inflammatory cytokine profiles, and autonomic imbalance that together increase risk of hypertension, diabetes, obesity, cardiovascular disease, and some inflammatory conditions. ^[20] Stress is also consistently linked to adverse mental health outcomes (anxiety, depression, burnout) and to behavioral patterns (poor sleep, substance use) that further worsen health. Evidence from randomized controlled trials and meta-analyses of stress-management programs and behavioral stress-reduction interventions indicates meaningful improvements in subjective stress, depressive symptoms, glycemic control, weight, and quality of life, suggesting that reducing stress can improve health outcomes and augment medical therapy, although effect sizes vary and many trials are small or heterogeneous. Recent reviews of stress and immunity describe an acute stress response that can temporarily enhance immune function but show that chronic stress impairs antibody production, T cell function, and immune regulation, promoting chronic low-grade inflammation, increased susceptibility to infections, and possibly higher risk of autoimmune disorders. Overall, high-quality evidence supports that chronic or intense psychological stress is an independent, modifiable risk factor for adverse physical and mental health outcomes and that structured stress-reduction interventions can yield clinically relevant benefits.

Contradicts

There is relatively little high-quality evidence directly contradicting the idea that stress affects health, but important caveats limit how broadly the claim can be applied. ^[22] Many observational studies rely on self-reported perceived stress and cannot fully disentangle stress itself from confounding factors such as socioeconomic status, pre-existing mental illness, or underlying disease, so causality is not always clear. Associations between stress and specific diseases (for example, particular cancers, autoimmune conditions, or gastrointestinal disorders) are less robust and sometimes inconsistent across studies; in these areas, evidence is suggestive rather than definitive, and some cohorts show weaker or non-significant relationships when fully adjusted for confounders. ^[17][21] Some stress-management intervention trials are small, short-term, or methodologically heterogeneous, which raises questions about generalizability; meta-analyses often note risk of bias and publication bias, and in some outcomes the effect sizes are modest. ^[24] Acute, short-lived stress responses can be adaptive and may even transiently enhance immune function or performance, so the blanket implication that all stress is harmful is not supported. Moreover, not everyone exposed to high stress develops disease; individual resilience, coping skills, and social support substantially modify risk, but these factors are not fully captured in many studies. ^[23] Guidelines for conditions like hypertension, cardiovascular disease, or inflammatory bowel disease increasingly acknowledge stress and psychosocial factors but still prioritize traditional biomedical risk factors and evidence-based drug and lifestyle therapies, reflecting the reality that effect sizes for stress, while important, are often smaller than for smoking, blood pressure, or lipids, and that the evidence base for precise, disease-specific stress targets is less mature. ^[18][19][20]

Mainstream view

The mainstream medical and scientific position is that chronic or high perceived psychological stress is a significant contributor to both mental and physical illness, acting through well-defined neuroendocrine, autonomic, inflammatory, and behavioral pathways, but it is one risk factor among many rather than a sole or universal cause of disease. ^[21][22][23] Clinical guidelines in major areas (cardiovascular disease, hypertension, diabetes, and chronic inflammatory conditions) increasingly recognize psychosocial stress as part of comprehensive risk assessment and recommend stress reduction, psychosocial support, and mental health care as components of holistic management, while continuing to emphasize established lifestyle measures (diet, physical activity, smoking cessation, sleep) and pharmacologic treatment. ^{[18][19][20][24]} Mainstream experts distinguish between acute, adaptive stress responses and chronic, unrelenting stress exposures; it is sustained, high-level stress, particularly combined with poor coping and limited social support, that is considered pathologic. The prevailing view is that stress meaningfully increases risk of cardiovascular disease, worsens mental health, impairs immune function, and can exacerbate many chronic conditions, and that structured stress-management interventions are beneficial and should be integrated into care, but that claims portraying stress as the primary or sole driver of most diseases, or implying that stress reduction

In their own wordsView sourceArchived copy

“Stress”

Rule: Minn. Stat. § 148.01, subd. 1(2), (6)

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Neonatal (colic, reflux, constipation, gas, irritability).

Neonatal (colic, reflux, constipation, gas, irritability)

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Neonatal (colic, reflux, constipation, gas, irritability)”

Rule: Minn. Stat. § 148.01

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Adolescent transitions (hormone changes, bed wetting, growth spurts).

Adolescent transitions (hormone changes, bed wetting, growth spurts)

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Adolescent transitions (hormone changes, bed wetting, growth spurts)”

Rule: Minn. Stat. § 148.01

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Birth trauma.

Birth trauma

Supports

Mainstream diagnostic systems and guidelines define psychological trauma as exposure to events involving actual or threatened death, serious injury, or sexual violence, experienced directly, witnessed, or learned about when they occur to close others.^[17][23] Trauma is recognized as a key contributor to mental health outcomes across the lifespan, associated with posttraumatic stress disorder (PTSD), depression, anxiety, substance use disorders, and other psychiatric conditions.^{[11][13][14][23]} Major guidelines for PTSD (e.g., from the American Psychological Association and WHO) explicitly anchor PTSD diagnosis in prior trauma exposure and document that such exposure can lead to persistent intrusive memories, avoidance, negative mood and cognition, and hyperarousal that interfere with functioning.^[13][14][18] Large epidemiologic surveys show that exposure to traumatic events is common worldwide and is associated with increased risk of mental and physical health problems, reinforcing the central role of trauma in public mental health.^{[1][2][9][23]} Clinical and cohort studies of physical trauma (e.g., major injuries) demonstrate high rates of new-onset mental health conditions and long-term psychological symptoms after trauma, supporting the claim that trauma has enduring health impacts.^{[4][5][10][23]} Scoping and focused reviews of trauma-informed care frameworks in mental health and general healthcare settings further support the notion that acknowledging trauma and adapting services to minimize re-traumatization can improve patient experience and may benefit outcomes, although the evidence base is still developing.^[3][6][7][8]

Contradicts

Although trauma is clearly associated with adverse mental health outcomes, high-quality evidence emphasizes that not everyone exposed to traumatic events develops PTSD or other psychiatric disorders, and many individuals show resilience or only transient distress.^{[1][2][11][13][14][23]} Overly broad influencer claims that equate any distressing experience with "trauma" or suggest that trauma inevitably causes chronic mental illness are not supported by mainstream definitions, which require events that are life-threatening or severely threatening to physical integrity, and emphasize heterogeneity of responses.^{[17][19][23][25]} Some popular narratives portray trauma-informed care as a fully validated, universally effective model across all healthcare settings, but systematic and scoping reviews highlight that the empirical evidence for specific trauma-informed interventions and their impact on hard clinical outcomes remains limited and methodologically variable, indicating that this area is still evolving rather than definitively established.^{[3][6][8][10]} If the influencer claims that trauma underlies virtually all medical or psychiatric conditions or that trauma is solely responsible for complex illnesses, this goes beyond current evidence, which recognizes trauma as an important but not exclusive determinant among multiple biological, psychological, and social factors.^{[13][17][19][23]}

Mainstream view

The mainstream medical and scientific position is that trauma refers to exposure to events involving actual or threatened death, serious injury, or sexual violence (including direct experience, witnessing, or learning about such events affecting close others), and that these experiences can lead to significant and sometimes long-lasting psychological and physical health consequences for a subset of exposed individuals.^{[11][13][14][17][19][23][25]} Trauma is considered a major risk factor for PTSD and a contributor to depression, anxiety, substance use disorders, and other mental health conditions, but responses are highly variable, with many people experiencing transient symptoms or demonstrating resilience.^{[11][13][14][17][23]} Guidelines for PTSD and complex trauma emphasize careful assessment of trauma history, evidence-based psychotherapies (such as trauma-focused cognitive behavioral therapies and EMDR), and a growing interest in trauma-informed approaches that seek to recognize trauma, avoid re-traumatization, and provide safe, collaborative care.^{[13][14][18][22][23]} At the same time, mainstream experts caution against pathologizing all adversity as trauma or assuming a simple, deterministic relationship between trauma and later illness; instead, they view trauma within a broader biopsychosocial framework that includes genetics, environment, social determinants, and ongoing stressors.^{[13][17][19][23]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Birth trauma”

Rule: Minn. Stat. § 148.01

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Auto Accidents.

Auto Accidents

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Auto Accidents”

Rule: Minnesota Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Webster technique.

Webster technique

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Webster technique”

Rule: Minnesota Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Shannon McCarty is not licensed or approved by Minnesota Board of Chiropractic Examiners to advertise Treatment of PTSD and Trauma as within their scope of practice.

Treatment of PTSD and Trauma

Supports

Mainstream diagnostic systems and guidelines define psychological trauma as exposure to events involving actual or threatened death, serious injury, or sexual violence, experienced directly, witnessed, or learned about when they occur to close others.^[17][23] Trauma is recognized as a key contributor to mental health outcomes across the lifespan, associated with posttraumatic stress disorder (PTSD), depression, anxiety, substance use disorders, and other psychiatric conditions.^{[11][13][14][23]} Major guidelines for PTSD (e.g., from the American Psychological Association and WHO) explicitly anchor PTSD diagnosis in prior trauma exposure and document that such exposure can lead to persistent intrusive memories, avoidance, negative mood and cognition, and hyperarousal that interfere with functioning.^[13][14][18] Large epidemiologic surveys show that exposure to traumatic events is common worldwide and is associated with increased risk of mental and physical health problems, reinforcing the central role of trauma in public mental health.^{[1][2][9][23]} Clinical and cohort studies of physical trauma (e.g., major injuries) demonstrate high rates of new-onset mental health conditions and long-term psychological symptoms after trauma, supporting the claim that trauma has enduring health impacts.^{[4][5][10][23]} Scoping and focused reviews of trauma-informed care frameworks in mental health and general healthcare settings further support the notion that acknowledging trauma and adapting services to minimize re-traumatization can improve patient experience and may benefit outcomes, although the evidence base is still developing.^[3][6][7][8]

Contradicts

Although trauma is clearly associated with adverse mental health outcomes, high-quality evidence emphasizes that not everyone exposed to traumatic events develops PTSD or other psychiatric disorders, and many individuals show resilience or only transient distress.^{[1][2][11][13][14][23]} Overly broad influencer claims that equate any distressing experience with "trauma" or suggest that trauma inevitably causes chronic mental illness are not supported by mainstream definitions, which require events that are life-threatening or severely threatening to physical integrity, and emphasize heterogeneity of responses.^{[17][19][23][25]} Some popular narratives portray trauma-informed care as a fully validated, universally effective model across all healthcare settings, but systematic and scoping reviews highlight that the empirical evidence for specific trauma-informed interventions and their impact on hard clinical outcomes remains limited and methodologically variable, indicating that this area is still evolving rather than definitively established.^{[3][6][8][10]} If the influencer claims that trauma underlies virtually all medical or psychiatric conditions or that trauma is solely responsible for complex illnesses, this goes beyond current evidence, which recognizes trauma as an important but not exclusive determinant among multiple biological, psychological, and social factors.^{[13][17][19][23]}

Mainstream view

The mainstream medical and scientific position is that trauma refers to exposure to events involving actual or threatened death, serious injury, or sexual violence (including direct experience, witnessing, or learning about such events affecting close others), and that these experiences can lead to significant and sometimes long-lasting psychological and physical health consequences for a subset of exposed individuals.^{[11][13][14][17][19][23][25]} Trauma is considered a major risk factor for PTSD and a contributor to depression, anxiety, substance use disorders, and other mental health conditions, but responses are highly variable, with many people experiencing transient symptoms or demonstrating resilience.^{[11][13][14][17][23]} Guidelines for PTSD and complex trauma emphasize careful assessment of trauma history, evidence-based psychotherapies (such as trauma-focused cognitive behavioral therapies and EMDR), and a growing interest in trauma-informed approaches that seek to recognize trauma, avoid re-traumatization, and provide safe, collaborative care.^{[13][14][18][22][23]} At the same time, mainstream experts caution against pathologizing all adversity as trauma or assuming a simple, deterministic relationship between trauma and later illness; instead, they view trauma within a broader biopsychosocial framework that includes genetics, environment, social determinants, and ongoing stressors.^{[13][17][19][23]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“PTSD”

Rule: Minn. Stat. § 148.01